360 trends tracked about this subject — the full history, oldest to newest below.
The US FDA has shelved its commissioner's priority review voucher pilot program for expedited drug reviews, according to exclusive reporting from Reuters and coverage across multiple outlets.
Christina Applegate reveals she is investigating whether breast implant illness caused her multiple sclerosis misdiagnosis, calling it potential 'poisoning.'
Moderna CEO Stéphane Bancel says the company's personalized mRNA cancer vaccine could work in "more cancers than melanoma" and aims for FDA approval by 2027, with shares up 750% in 2026.
New research links energy drink consumption to dramatically higher cardiac arrest reports among young adults, prompting urgent medical review.
The FDA warns that widely used GLP-1 medications like Ozempic and Zepbound carry a potential risk of vision loss.
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
The Food and Drug Administration mandates safety label changes for GLP-1 medications following potential rare eye condition risks.
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
Federal regulators issue a new warning regarding GLP-1 medications and a rare eye condition linked to sudden blindness.
The FDA is requiring all GLP-1 drug makers to add a warning about NAION, a rare eye condition that can cause sudden blindness, to their prescribing information.
HHS Secretary Robert F. Kennedy Jr. announced a new policy allowing licensed pharmacies and physicians to compound six unapproved peptides.
Opposing sides file final briefs as a critical federal marijuana rescheduling hearing approaches a judge's decision.
The FDA launches an investigation into Novartis' Zolgensma gene therapy following reports of new tumor cases.
The US Food and Drug Administration and Health Canada have approved bepirovirsen, marketed as Hibsago, as the first functional cure for chronic hepatitis B.
Doctors warn of slight cancer risk with hormone therapy for menopause
Recent reporting examines the clinical capabilities, limitations, and new availability of FDA-cleared Alzheimer's blood tests.
AstraZeneca reportedly made a $10 billion acquisition offer for obesity drugmaker Rhythm Pharmaceuticals.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Samsung expands its upgraded sleep apnea screening feature to the Galaxy Ring and Galaxy Watch 9 after regulatory approvals.
Ultragenyx Pharmaceutical reports third-quarter 2026 results while announcing major workforce reductions and pipeline cuts to target profitability.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Usona has filed a New Drug Application for its psilocybin depression treatment, intensifying the competitive race with Compass Pathways for FDA approval.
The FDA has approved the first generic version of the HIV-prevention shot lenacapavir, aiming to expand healthcare access for lower-income countries.
A nationwide recall of thousands of blood pressure medication bottles is underway following failed quality tests.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New research presented at the American Heart Association Scientific Sessions 2026 links energy drinks and stimulant supplements to significantly higher reporting odds of cardiac arrest, heart attacks, and arrhythmias in young adults.
A popular children's snack faces an official recall warning over a potential choking hazard for toddlers.
A popular toddler snack sold at major retailers Walmart and Target faces a recall due to a fatal choking risk.
New guidance and shifts in hormone therapy are drawing widespread attention to menopause care and treatment options.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
RFK Jr. plans to bypass FDA regulations to allow the temporary sale of six unapproved peptides, sparking reactions from industry proponents.
Health Secretary Kennedy faces scientific opposition after opening broad access to unapproved peptide injections.
FDA scientists opposed the Trump administration's initiative to ease access to unapproved peptides.
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA issues a risk warning and recall for plant-based butter across multiple states due to yeast, mold, and E. coli.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
US cancer patients are traveling to China to access innovative oncology therapies and lifesaving drugs not yet available within the United States.
A startup deploys an artificial intelligence-designed virus in a human patient for the first time.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Federal regulators have announced a nationwide recall affecting more than four million tubes of adult and children's toothpaste.
Over four million tubes of adult and children's toothpaste face a nationwide recall flagged by the FDA.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
FDA moves to curb bulk compounding of GLP‑1 weight‑loss drugs as legal action hits telehealth firm HIMS
Tougher federal worker evaluations and senior professional rating policy changes roll out, sparking widespread morale concerns.
19 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.